Cargando…
Promises and pitfalls for recombinant oligoclonal antibodies-based therapeutics in cancer and infectious disease
Monoclonal antibodies (mAbs) have revolutionized the diagnosis and treatment of many human diseases and the application of combinations of mAbs has demonstrated improved therapeutic activity in both preclinical and clinical testing. Combinations of antibodies have several advantages such as the capa...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127534/ https://www.ncbi.nlm.nih.gov/pubmed/26995095 http://dx.doi.org/10.1016/j.coi.2016.03.001 |